- Global Pharma News & Resources

Glyn R. Morgan, MD, Named Director Of Loyola Medicine's Division Of Intra-Abdominal Transplant

Glyn R. Morgan, MD, Named Director Of Loyola Medicine's Division Of Intra-Abdominal Transplant

PR Newswire

MAYWOOD, Ill., Oct. 25, 2018

MAYWOOD, Ill., Oct. 25, 2018 /PRNewswire/ -- Glyn R. Morgan, MD, MSc, FRCSC, FACS, one of the nation's leading liver and kidney transplant surgeons, has been named director of Loyola Medicine's division of intra-abdominal transplant.

Before joining Loyola, Dr. Morgan was director of liver transplantation at the NYU Langone Transplant Institute in New York City, where he co-founded the NYU living donor liver transplant program.

Dr. Morgan has performed nearly 700 liver transplants - including more than 100 living donor liver transplants - and more than 200 kidney transplants.

At Loyola, Dr. Morgan plans to recruit new transplant surgeons; enhance clinical excellence and outcomes; increase the number of kidney, liver and pancreas transplants; create and grow a living donor liver program; advance the educational profile of the intra-abdominal transplant division for medical students and residents; establish an American Society of Transplant Surgeons fellowship program; and elevate clinical and translational research.

Dr. Morgan earned his MD and MSc degrees from the University of Toronto, where he also completed a residency in surgery. He completed a fellowship in pediatric liver transplantation at the Hospital for Sick Children in Toronto and an ASTS-accredited transplant surgery fellowship in liver transplantation and hepatobiliary surgery at Cedars-Sinai Medical Center in Los Angeles.

Dr. Morgan is a professor in the department of surgery of Loyola University Chicago Stritch School of Medicine. He is a fellow of the American College of Surgeons and a fellow of the Royal College of Physicians of Canada. He is board certified in surgery.

Loyola Medicine offers the highest level of multidisciplinary, integrated care for liver disease and liver failure patients who may be considering a liver transplant and for kidney disease and kidney failure patients who may be considering a kidney transplant. Loyola takes on the most challenging cases, including patients who have been turned away by other centers.

This news release was issued on behalf of Newswise™. For more information, visit


View original content:

SOURCE Loyola University Health System

Editor Details

Last Updated: 25-Oct-2018